Functional precision cancer medicine-moving beyond pure genomics
- PMID: 28886003
- DOI: 10.1038/nm.4389
Functional precision cancer medicine-moving beyond pure genomics
Abstract
The essential job of precision medicine is to match the right drugs to the right patients. In cancer, precision medicine has been nearly synonymous with genomics. However, sobering recent studies have generally shown that most patients with cancer who receive genomic testing do not benefit from a genomic precision medicine strategy. Although some call the entire project of precision cancer medicine into question, I suggest instead that the tools employed must be broadened. Instead of relying exclusively on big data measurements of initial conditions, we should also acquire highly actionable functional information by perturbing-for example, with cancer therapies-viable primary tumor cells from patients with cancer.
Similar articles
-
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.Oncologist. 2017 Feb;22(2):144-151. doi: 10.1634/theoncologist.2016-0195. Epub 2017 Feb 8. Oncologist. 2017. PMID: 28179575 Free PMC article.
-
Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.Am Soc Clin Oncol Educ Book. 2015:e175-82. doi: 10.14694/EdBook_AM.2015.35.e175. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993170 Free PMC article. Review.
-
Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observation.Ann Oncol. 2013 Aug;24(8):1956-7. doi: 10.1093/annonc/mdt273. Ann Oncol. 2013. PMID: 23878114 No abstract available.
-
Widespread Genomic Testing Deemed Feasible.Cancer Discov. 2017 Aug;7(8):786-787. doi: 10.1158/2159-8290.CD-NB2017-094. Epub 2017 Jun 22. Cancer Discov. 2017. PMID: 28642250
-
Implementing precision cancer medicine in the genomic era.Semin Cancer Biol. 2019 Apr;55:16-27. doi: 10.1016/j.semcancer.2018.05.009. Epub 2018 May 30. Semin Cancer Biol. 2019. PMID: 29857039 Review.
Cited by
-
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.Commun Biol. 2024 Oct 20;7(1):1355. doi: 10.1038/s42003-024-07004-9. Commun Biol. 2024. PMID: 39427059 Free PMC article.
-
Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform.Sci Adv. 2024 Sep 6;10(36):eadn5875. doi: 10.1126/sciadv.adn5875. Epub 2024 Sep 6. Sci Adv. 2024. PMID: 39241078 Free PMC article.
-
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology.Cancers (Basel). 2024 Jul 27;16(15):2677. doi: 10.3390/cancers16152677. Cancers (Basel). 2024. PMID: 39123405 Free PMC article. Review.
-
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.Int J Mol Sci. 2024 Jun 28;25(13):7131. doi: 10.3390/ijms25137131. Int J Mol Sci. 2024. PMID: 39000238 Free PMC article. Review.
-
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.bioRxiv [Preprint]. 2024 Jun 10:2024.06.06.597767. doi: 10.1101/2024.06.06.597767. bioRxiv. 2024. PMID: 38915726 Free PMC article. Preprint.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous